chlorzoxazone has been researched along with chlormethiazole in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dai, R; Liu, Y; She, M; Wu, Z | 1 |
Baldwin, HA; Cross, AJ; Ingelman-Sundberg, M; Tindberg, N | 1 |
Gebhardt, AC; Lucas, D; Ménez, JF; Seitz, HK | 1 |
Besson, J; Buclin, T; Eap, CB; Savary, L; Schnyder, C | 1 |
Ingelman-Sundberg, M; Simi, A | 1 |
Donohue, TM; Fang, C; French, BA; French, SW; Fu, P; Gouillon, Z; Hagbjork, AL; Ingelman-Sundberg, M; Li, J; Lucas, D | 1 |
Blanchard, AP; Creegan, TP; Dehal, SS; Gangl, ET; Mason, AK; Perloff, ES; Singh, R; Stresser, DM | 1 |
8 other study(ies) available for chlorzoxazone and chlormethiazole
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The inhibition study of human UDP-glucuronosyltransferases with cytochrome P450 selective substrates and inhibitors.
Topics: Cytochrome P-450 Enzyme Inhibitors; Enzyme Activation; Enzyme Inhibitors; Glucuronosyltransferase; Humans; Molecular Structure; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity | 2011 |
Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury.
Topics: Animals; Astrocytes; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Chlormethiazole; Chlorzoxazone; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Enzyme Induction; Enzyme Inhibitors; Gerbillinae; Hydroxylation; Inflammation; Interleukin-1; Kinetics; Lipopolysaccharides; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1996 |
Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans.
Topics: Adult; Aged; Alcoholism; Chlormethiazole; Chlorzoxazone; Cytochrome P-450 CYP2E1 Inhibitors; Enzyme Inhibitors; Female; Humans; Hydroxylation; Male; Middle Aged; Substance Withdrawal Syndrome | 1997 |
Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
Topics: Administration, Oral; Adult; Alcoholism; Anticonvulsants; Area Under Curve; Chlormethiazole; Chlorzoxazone; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central | 1998 |
Post-translational inhibition of cytochrome P-450 2E1 expression by chlomethiazole in Fao hepatoma cells.
Topics: Animals; Anticonvulsants; Blotting, Northern; Chlormethiazole; Chlorzoxazone; Cricetinae; Cycloheximide; Cytochrome P-450 CYP2E1; Humans; Hydroxylation; Liver Neoplasms, Experimental; Microsomes, Liver; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection; Tumor Cells, Cultured | 1999 |
Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole.
Topics: Animals; Apoenzymes; Body Weight; Chlormethiazole; Chlorzoxazone; Chymotrypsin; Cysteine Endopeptidases; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Disease Models, Animal; Ethanol; Hydroxylation; Immunohistochemistry; Liver; Liver Diseases, Alcoholic; Male; Multienzyme Complexes; Organ Size; Proteasome Endopeptidase Complex; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Trypsin | 2000 |
Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole.
Topics: Biotransformation; Chlormethiazole; Chlorzoxazone; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Hydroxylation; Hypnotics and Sedatives; Kinetics; Liver; Male; Microsomes, Liver; Models, Biological; NADP; Risk Assessment; Substrate Specificity | 2016 |